1-4 of 4
Wynne Weston-Davies
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Nomacopan Administration Results in Complete Transfusion Independence in Previously Transfusion-Dependent PNH Patients

Austin Kulasekararaj, MBBS MDMRCP FRCPath, Wynne Weston-Davies, Tadeusz Robak, MD, Miles Nunn, PhD, Agnieszka Piekarska, MD, Anna Szmigielska-Kaplon, MD, Anita Hill, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4797.
https://doi.org/10.1182/blood-2019-125263
Published: 2019
Journal Articles

Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial

Anita Hill, MBChB (Hons), PhD, Wynne Weston-Davies, MB FRCS, Miles Nunn, PhD, Tadeusz Robak, MD PhD, Jerzy Windyga, MD, Andrzej Hellmann, MD PhD DSc, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Agniezka Piekarska, Anna Szmigielska-Kaplon, Morag Griffin, Talha Munir
Journal: Blood
Blood (2017) 130 (Supplement 1): 4747.
https://doi.org/10.1182/blood.V130.Suppl_1.4747.4747
Published: 2017
Journal Articles

C5 Polymorphism in a Dutch Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH) and No Asian Ancestry, Resistant to Eculizumab, but in Vitro Sensitive to Coversin

Saskia Langemeijer, MD PhD, Jun-Ichi Nishimura, MD PhD, Wynne Weston-Davies, Miles A Nunn, DPhil, Yuzuru Kanakura, MD PhD, Ian J Mackie, Petra Muus, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1209.
https://doi.org/10.1182/blood.V126.23.1209.1209
Published: 2015
Journal Articles

Coversin Blocked in Vitro Hemolysis in an Eculizumab-Resistant PNH Patient with the C5 Polymorphism (c.2654G>A)

Yasutaka Ueda, MDPhD, Makiko Osato, DS, Wynne Weston-Davies, MB FRCS, Miles A Nunn, DPhil, Satoru Hayashi, Jun-Ichi Nishimura, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2138.
https://doi.org/10.1182/blood.V126.23.2138.2138
Published: 2015